SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending as investors digest recent earnings and future guidance; while revenue and EPS beat expectations, a lowered full-year 2025 outlook due to third-party data center delays has sparked mixed reactions. The community is weighing the significance of a massive $55.6 billion backlog against concerns about profitability and debt, with some viewing the dip as a buying opportunity in a high-growth AI play. Analyst upgrades are adding fuel to the debate, highlighting the company's potential in the AI-as-a-service market.

STMicroelectronics NV is a global semiconductor company, which engages in the business of designing, developing, manufacturing, and marketing products used in a wide variety of applications for automotive, industrial, personal electronics and communications equipment, computers, and peripherals. It operates through the following segments: Automotive and Discrete Group (ADG), Analog, MEMS, and Sensors Group (AMS), Microcontrollers and Digital ICs Group (MDG), and Others. The ADG segment includes dedicated automotive integrated circuits and discrete and power transistor products. The AMS segment offers analog, smart power, MEMS sensors and actuators, and optical sensing solutions. The MDG segment focuses on general-purpose microcontrollers and microprocessors, connected security products, memories, and RF and communications products. The Others segment is involved in sales assembly services and other revenues. The company was founded in June 1987 and is headquartered in Plan-Les-Ouates, Switzerland.

ST Microelectronics - New York Shares

STMicroelectronics NV

STM is trending amid discussions around its AI solutions and expansion in chip manufacturing. Community members are analyzing the stock's recent price movement relative to bullish news and analyst ratings. The company's involvement in edge AI, automotive technology, and sustainability initiatives are also key talking points.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai (BBAI) is trending as investors discuss its latest earnings and the acquisition of Ask Sage, a generative AI platform. Community members are weighing the potential benefits of the acquisition against concerns about revenue decline and government spending cycles, while others are optimistic about the company's future in the AI-driven defense sector.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is trending amid increasing discussion around the company's advancements in robotics and AI, including humanoid robots and self-driving technology. Community members highlight XPeng's growth in overseas markets and its partnership with Volkswagen as key factors driving optimism, positioning it as a strong contender in the EV space.

Veterans Recognition Currency

Veterans Recognition Currency ($VETERANS) is trending as traders discuss its chart patterns and community-driven mission. Talk centers on the token's commitment to donating to veteran charities, with some highlighting the disciplined and strategic approach to trading it. However, concerns have also emerged regarding the legitimacy of the project and its use of veteran imagery.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending due to its acquisition of Damora Therapeutics and a large concurrent private placement, shifting its focus to hematologic malignancies and extending its cash runway. The community is discussing the potential for a short squeeze given the low float and high cost to borrow, with some eyeing the stock as a multi-day runner while others remain cautious. Some traders are also noting that the recent private placement may introduce additional shares to the market, and will continue to monitor price action.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano (MOVE) is trending due to merger news, with the community actively discussing the potential impact on the stock's valuation and a possible short squeeze. Some traders are focusing on the low float and merger news, while others are wary of dilution. Bullish sentiment seems high amidst conversation of a potential short squeeze, with community members sharing entry and exit strategies.

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.

Precision Biosciences Inc

Precision BioSciences is trending due to the announcement of a $75 million offering, sparking debate within the community about dilution and the company's financial strategy. While some investors express concern and accuse the company of exploiting retail investors, others point to recent positive Phase 1 data on their Hepatitis B therapy as a potential long-term catalyst, with some bullish investors viewing the pullback as a buying opportunity.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap is currently trending as community members discuss a potential fee switch activation, which could redirect trading fees to UNI holders and the DAO treasury. Traders are actively watching for breakout opportunities and analyzing charts, with some anticipating a move towards previous all-time highs. Bullish sentiment is fueled by the anticipation of increased revenue streams for UNI holders.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors anticipate potential news from an upcoming CHMP meeting regarding its Alzheimer's drug, Blarcamesine. Community members are debating the likelihood of approval, speculating on potential conditional approvals, and discussing the implications of the oral explanation session. Despite bearish technical indicators, many express optimism, citing the drug's unique mechanism and strong long-term data, while closely watching for news of partnerships or a potential buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
